Frontiers is back! This hybrid event will take place April 19-20, 2023 in lovely La Jolla, with a view of the Pacific Ocean.
You’ll enjoy two full days of learning about the latest in the use of rapid Whole Genome Sequencing™ for saving critically ill infants, and the promise of genomic sequencing in newborn screening.
Frontiers in Pediatric Genomic Medicine is our annual virtual conference covering the new standard of care created by Rapid Precision Medicine™.
Connect with colleagues by the beautiful beaches of La Jolla, California.
Log in using the vFairs platform.
Mingle with international leaders in genomics and healthcare
Live chat with other virtual attendees — now integrated throughout the entire conference
Find us on LinkedIn
8610 Kennel Way
La Jolla, CA 92037
Curio Collection by Hilton
7955 La Jolla Shores Drive
La Jolla, CA 92037
Frontiers 2024 special rate only available until March 31.
Hotel La Jolla bookings include:
The annual Frontiers in Pediatric Genomic Medicine Conference brings leaders in research, industry and healthcare together to explore advances in translating genomic diagnostics into targeted treatment for patients in neonatal and pediatric intensive care. This year's program will focus on the topics of Rapid Whole Genome Sequencing in Behavioral Health & Neuro-Oncology and Newborn Genomic Sequencing
At the conclusion of this conference, the participants should be able to:
This activity is intended for the Genomic Community.
Genomic medicine is a new healthcare approach that utilizes various technologies to accurately identify patients with specific variations in human genes that result in disease and mortality. It is a large, somewhat diffuse field of study that encompasses diverse disciplines. While the practice of whole genomic sequencing could be a key technology leveraged by NICUs and PICUs to assist in making treatment decisions of acutely-ill babies, a pediatric genomic medicine knowledge gap currently exists between many healthcare providers in the United States. Genomic medicine is a relatively recent development in the healthcare sphere introduced only 15 years ago with the completion of the first human genome. Incorporating genomics into clinical decision making has only been feasible with the advent of improved technologies allowing cost-effective genomic analysis. Genomic diagnostic and decision-making tools are being developed at a higher rate now than ever before. Unfortunately, didactic coursework in healthcare curricula that prepares healthcare professionals to utilize genomic medicine has been slow to catch up. This has left many practicing healthcare professionals in the workforce without formal training in pediatric genomic medicine, which is hampering the adoption of genomics in the care of acutely-ill children.
It is the policy of University of California San Diego School of Medicine Continuing Professional Development to ensure that the content of accredited continuing education and related materials is accurate, balanced, objective, and scientifically justified. Education must be free of the influence or control of ineligible companies, and protect learners from promotion, marketing, and commercial bias. All persons in a position to control the content of accredited continuing education must disclose all financial relationships held with ineligible companies, prior to assuming a role in the activity. Those relationships deemed relevant to the education are mitigated prior to the activity through one of the following strategies, depending on the nature of relationship and the role of the person: 1) divesting the financial relationship, 2) altering the individual’s control over content, and/or 3) validating the planning decisions and/or content through independent peer review. All relevant financial relationships are mitigated prior to the activity and mitigation strategies and necessary steps for implementation are communicated to individuals prior to them assuming their role in the activity. Persons who refuse or fail to disclose are disqualified from participating in the activity. Activities are evaluated by participants and peer reviewers to determine if the content was free of bias and met acceptable scientific standards. This information is considered in future activity planning. All relevant financial relationships and the nature of those relationships are noted below. All relevant financial relationships have been mitigated.
Faculty Member Name | Role in Activity | Name of Ineligible Company(ies)/Nature of Relationship(s) |
Jonathan Santoro, MD | Faculty | Consulting Fee-UCB | Consulting Fee-Cycle Pharmaceuticals | Consulting Fee-TG Therapeutics |
This conference greatly increased confidence in my genomic knowledge.”
Comprehensive and engaging.”
The virtual platform is designed to feel like an in-person conference.”
Frontiers registrants receive free access to Genomics 101. The RCIGM Genomics 101 course is designed to provide non-geneticists with a basic knowledge of genomics and genomic medicine at the Rady Children’s Institute for Genomic Medicine.
The 2020, 2021, and 2023 Frontiers in Pediatric Genomic Medicine Conference videos are available on demand via the free RCIGM Learning Network.
RCIGM Learning Network registration required.
© 2024 Rady Children's Institute for Genomic Medicine.